Reissigl et al., " Improvement of Prostate Cancer Screening by Determination of the Ratio Free/Total PSA in Addition to PSA Levels, " Prostate, 30(4), Mar. 1, 1997, pp. 243-247.Reissigl A, Klocker H, Pointner J, Ennemoser O, Falk M, Bartsch G. Improvement of prostate ...
To examine the distribution of total prostate-specific antigen (tPSA) and percentage of free/total PSA (%f/tPSA) values in patients undergoing prostate cancer screening in Canada.MethodsThe data from 4 consecutive annual prostate cancer screening events held in Montreal, Canada were examined with ...
[22] Ulmert D, Becker C, Nilsson JA, Piironen T, Björk T, Hugosson J, Berglund G, Lilja H. Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long...
INTENDED USE PSA Rapid Test (the Test) is a simple, rapid, and qualitative test for the detection of Protate Specific Antigen (PSA) in human serum or plasma. The Test is intended primarily as an initial screening test and positive samples should be tested by a confirmartory quantitative assa...
A total of 30,150 men were at risk, or eligible, for screening, and 2,001 men were screened. The mean monthly screening rate during the 15-month baseline period was 8.3 %, and during the 15-month intervention period, was 4.6 %. The screening rate declined by 38 % during the baseline...
but not dead from pc because of early detection by screening Weighted total 78.46 7.10 11.50 1.89 1.05 100.00 0.00 10.69 5.43 6.97 9.15 1.61 0.00 0.00 0.00 0.00 8.57 0.09 Consequences of PSA screening for the individual EM Wever et al 44.0–5.3% in the event that they are diagnosed and tre...
Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels In a retrospective study, we tested whether free/total PSA helps to distinguish between BPH and prostatic carcinoma in men with elevated serum PSA.METHODS... A Reissigl,H Klocker,J...
(prostate-specific antigen, PSA)密度(TZPSAD)在PSA4.0～10.0和10.1～20.0ng/ml时诊断前列腺癌的作用;(3)年龄≤50岁非前列腺癌男性初始PSA及PSA速度的分布特点分析;(4)前列腺体积(PV)在PSA10.0～50.0ng/ml时对前列腺癌诊断的预测作用;(5)探讨f/tPSA (free/total PSA, f/t PSA)在PSA4.0～20.0ng/ml时...
The activation rate of pro-MMP2 (0.14 µM) and hydrolysis of IGFBP-3 by the PSA protein variants (0.07 µM) was determined by a MMP2 screening assay (Abcam) and an immunofluorometric assay to detect intact and total IGFBP-3, respectively. Three technical replicates per group ...
FULL PAPER British Journal of Cancer (2014) 110, 2829–2836 | doi: 10.1038/bjc.2014.242 Keywords: cluster randomised controlled trial; screening; prostate cancer; prostate-specific antigen; prostate cancer mortality; cost-effectiveness Design and preliminary recruitment results of the Cluster randomised ...